Fukutin-related protein (FKRP) is a protein involved in the glycosylation of cell surface molecules. Pathogenic mutations in the FKRP gene cause both the more severe congenital muscular dystrophy Type 1C and the milder Limb-Girdle Type 2I form (LGMD2I). Here we report muscle histological alterations and the analysis of 11 muscle proteins: dystrophin, four sarcoglycans, calpain 3, dysferlin, telethonin, collagen VI, alpha-DG, and alpha2-laminin, in muscle biopsies from 13 unrelated LGMD2I patients with 10 different FKRP mutations. In all, a typical dystrophic pattern was observed. In eight patients, a high frequency of rimmed vacuoles was also found. A variable degree of alpha2-laminin deficiency was detected in 12 patients through immunofluorescence analysis, and 10 patients presented alpha-DG deficiency on sarcolemmal membranes. Additionally, through Western blot analysis, deficiency of calpain 3 and dystrophin bands was found in four and two patients, respectively. All the remaining proteins showed a similar pattern to normal controls. These results suggest that, in our population of LGMD2I patients, different mutations in the FKRP gene are associated with several secondary muscle protein reductions, and the deficiencies of alpha2-laminin and alpha-DG on sections are prevalent, independently of mutation type or clinical severity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2569900PMC
http://dx.doi.org/10.1369/jhc.2008.951772DOI Listing

Publication Analysis

Top Keywords

lgmd2i patients
12
muscle protein
8
patients mutations
8
fukutin-related protein
8
mutations fkrp
8
fkrp gene
8
patients
7
muscle
5
protein alterations
4
lgmd2i
4

Similar Publications

Objective: Limb-girdle muscular dystrophy R9 (LGMDR9, formerly known as LGMD2I), caused by variants in the fukutin-related protein (FKRP) gene leads to progressive muscle weakness of the shoulder and pelvic limb-girdles and loss of motor function over time. Clinical management and future trial design are improved by determining which standardized clinical outcome assessments (COA) of function are most appropriate to capture disease presentation and progression, informing endpoint selection and enrollment criteria. The purpose of our study was to evaluate the cross-sectional validity and reliability of clinical outcome assessments in patients with FKRP-related LGMDR9 participating in the Genetic Resolution and Assessments Solving Phenotypes in LGMD (GRASP) natural history study.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic variants in the FKRP gene cause various muscular dystrophies, including Limb-Girdle Muscular Dystrophy type 9 (LGMDR9), which is notably prevalent in Italy.
  • A study analyzed 153 patients from Southern Italy showing Duchenne/Becker-like symptoms, identifying pathogenic variants in 16 individuals, with specific variants frequently found.
  • The findings emphasize the need to include LGMDR9 in the diagnosis of dystrophinopathies, aiming to improve the identification and management of affected patients in Calabria.
View Article and Find Full Text PDF
Article Synopsis
  • Three types of muscular dystrophy, called dystroglycanopathies, are linked to problems in the ribitol pathway and involve specific gene mutations.
  • Ribose supplementation was tested in a patient with limb girdle muscular dystrophy type 2I, showing it was well tolerated and led to significant increases in a beneficial compound (CDP-ribitol) and a decrease in muscle enzyme levels.
  • Although the clinical and patient-reported outcomes didn't show objective improvements, the patient felt subjective benefits in muscle strength, fatigue, and pain, suggesting more research is needed on ribose's effects.
View Article and Find Full Text PDF

The cell membrane protein, dystroglycan, plays a crucial role in connecting the cytoskeleton of a variety of mammalian cells to the extracellular matrix. The α-subunit of dystroglycan (αDG) is characterized by a high level of glycosylation, including a unique O-mannosyl matriglycan. This specific glycosylation is essential for binding of αDG to extracellular matrix ligands effectively.

View Article and Find Full Text PDF
Article Synopsis
  • Limb-girdle muscular dystrophies (LGMDs) are inherited disorders that primarily lead to muscle weakness and vary in subtype prevalence across different regions and ethnic groups in China, with common types identified among patients in Southeast China.
  • In a study of 81 patients from 62 families, the most frequent LGMD subtypes were LGMD-R2 (LGMD2B) and LGMD-R1 (LGMD2A), along with specific genetic mutations being more prevalent in certain subtypes, particularly those affecting childhood-onset cases.
  • Patients exhibited various clinical issues, including cardiac problems and respiratory insufficiency, while muscle imaging revealed distinct patterns of fatty infiltration and edema based on the LGMD subtype.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!